TGA Sciences, Inc. is a contract research organization (CRO) providing the Pharmaceutical, Biotechnology and Academic communities a comprehensive range of laboratory services in support of basic research and development as well as for clinical studies. They serve clients both in the U.S. and internationally.

TGA Sciences, Inc. offers the client a complete package of customized testing systems utilized in pre-clinical through Phase IV studies. TGA Sciences, Inc. (FDA/EMA registered and inspected) provides GLP and cGMP regulatory-compliant services for FDA/EMA-level applications and submissions when requested by the client. They offer dedicated QA/QC personnel to insure compliance to required guidelines. TGA Sciences, Inc. specializes in the development and validation of immunoassay systems for the detection of target molecules, antibody responses, and quantification.

 

Contact information:

Address:
47 Hall Street 
Medford, MA 02155
USA

Website: www.tgasciences.com

e-mail: msettles@tgasciences.com

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.